Top compounds associated with response to RP11-1012A1.4


Feature Type Standardized
Nominal ANOVA
mRNA ML210 CTRPv2 pan-cancer AAC -0.074 0.06
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.076 0.06
mRNA AZD4547 CTRPv2 pan-cancer AAC -0.08 0.06
mRNA SB-431542 CTRPv2 pan-cancer AAC -0.082 0.06
mRNA RITA CTRPv2 pan-cancer AAC -0.078 0.06
mRNA KHS101 CTRPv2 pan-cancer AAC 0.079 0.06
mRNA neratinib CTRPv2 pan-cancer AAC -0.077 0.07
mRNA BRD-K09344309 CTRPv2 pan-cancer AAC -0.17 0.07
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC -0.078 0.07
mRNA CD-1530 CTRPv2 pan-cancer AAC -0.078 0.07
Download CSV